Dr. Sauter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce Street
Philadelphia, PA 19104Phone+1 215-662-2250
Summary
- I am a Medical Oncologist and FDA Medical Officer im CDER/DHM2 (Lymphoma & Myeloma). My clinical interest is in lymphomas and myelomas. My academic interests are in cellular therapies and use of AI and RWE.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2020 - 2024- University of Pennsylvania Health SystemResidency, Internal Medicine, 2017 - 2020
Emory University School of MedicineClass of 2016
Certifications & Licensure
PA State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsThe BTLA-HVEM axis restricts CAR T cell efficacy in cancer.Puneeth Guruprasad, Alberto Carturan, Yunlin Zhang, Jong Hyun Cho, Kingsley Gideon Kumashie
Nature Immunology. 2024-06-01 - 10 citationsApoptosis: ain T-cell immunotherapy.Yong Gu Lee, Nicholas Yang, Inkook Chun, Patrizia Porazzi, Alberto Carturan
Journal for Immunotherapy of Cancer. 2023-04-01 - 34 citationsModulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, Raymone Pajarillo, Christopher Tor Sauter
Cancer Discovery. 2022-10-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
